# Will CDC report 10,000 or more H5 avian influenza cases in the United States before January 1, 2026? (QID: 38738)

- Type: binary

- URL: https://www.metaculus.com/questions/38738/

- Classifier: health | strategic=False (score=0.00)

### SeenGuard

- enabled=True | lock_status=acquired

- run_filter: before=1 | skipped=0 | after=1

- debug_note=lock acquired

## Research (summary)

CALIBRATION GUIDANCE (auto-generated weekly):
BINARY CALIBRATION
- No resolved binary questions (with pre-resolution forecasts) yet.
- Advice: keep using base rates + small evidence-weighted updates; avoid big swings.

MULTIPLE-CHOICE CALIBRATION (Top-1)
- No resolved MCQ questions (with pre-resolution forecasts) yet.

NUMERIC CALIBRATION (PIT-lite + CRPS)
- No resolved numeric questions (with pre-resolution forecasts) yet.
- When numeric results exist, we’ll check p10/p50/p90 coverage and CRPS.

General takeaway: apply **small** nudges only where gaps are consistent with decent sample sizes (≥10).
— end calibration —

### Reference class & base rates
-   **Sporadic Zoonotic Spillover Events (e.g., historical H5N1, MERS-CoV in the US, Hantavirus):** These events typically result in a very small number of human cases, often in the single or double digits annually. The base rate of such an event exceeding 10,000 cases in the US is extremely low, effectively near 0%. This class represents the status quo for H5N1 for the last two decades.
-   **Contained but Significant Novel Outbreaks (e.g., Mpox 2022-23, SARS-CoV-1 2003):** These outbreaks demonstrate that a novel virus can establish some community transmission and reach significant numbers. Mpox exceeded 30,000 US cases. SARS-CoV-1 was contained globally with only a handful of probable cases in the US. The base rate for a novel zoonosis reaching >10,000 cases in the US, based on the last 20 years, might be around 5-10% (1 significant event, Mpox, out of ~10-20 notable zoonotic threats).
-   **Pandemic Influenza (e.g., H1N1 2009):** This class involves a novel influenza virus capable of efficient and sustained human-to-human transmission. Such events lead to millions of cases, far exceeding the 10,000 threshold. Historically, these occur every 10-50 years, suggesting a raw annual base rate of 2-10%. However, this applies to *any* novel influenza strain, not specifically H5N1. The probability of H5N1 *becoming* a pandemic strain is the key uncertainty.

### Recent developments (timeline bullets)
-   [2024-12-05] Research identifies single Q226L mutation as sufficient for human receptor binding. — ↑ — Dramatically clarifies the specific, simple genetic change required for the virus to adapt for human-to-human spread, lowering the perceived barrier to a pandemic.
-   [2024-12-11] CDC reports 58 cumulative human cases in 2024, primarily linked to cattle. — ↑ — This number, while small, is a massive increase from the US historical baseline (1 case before 2024), confirming ongoing spillover from the new mammalian reservoir.
-   [2025-03-15] Hypothetical: Wisconsin reports a small cluster of H5 cases among family members of a dairy worker with no direct animal contact. — ↑ (large) — This would be the first strong evidence of human-to-human (H2H) transmission on US soil, the most critical step toward widespread outbreak.
-   [2025-05-20] Hypothetical: CDC reports H5N1 detected in wastewater surveillance in a major metropolitan area far from known agricultural outbreaks. — ↑ (large) — Suggests cryptic, unmonitored community spread, implying the official case count is a significant undercount and that H2H transmission is established.
-   [2025-07-01] Hypothetical: FDA authorizes emergency use of an updated H5N1 candidate vaccine and distribution begins for at-risk workers. — ↓ — A key countermeasure becomes available. Its effectiveness in preventing transmission (not just severe disease) would be the critical factor in slowing spread.

### Mechanisms & drivers (causal levers)
-   **Viral Adaptation for H2H Transmission:** The acquisition of key mutations (like Q226L) that allow the virus to efficiently bind to human upper-respiratory tract receptors. This is the primary, non-negotiable driver for a large-scale outbreak. **Size: Large**.
-   **Mammalian Reservoir Size & Density:** The ongoing, widespread H5N1 outbreak in US dairy cattle provides a vast new environment for the virus to replicate and evolve, increasing the probability of mutations favorable for human infection. **Size: Moderate**.
-   **Surveillance, Testing, and Reporting Capacity:** The number of *reported* cases is a direct function of testing strategy. A shift from testing only symptomatic, exposed individuals to broader surveillance or syndromic testing could dramatically increase case counts. **Size: Moderate**.
-   **Asymptomatic or Mild Transmission:** If the virus adapts to spread from individuals with mild or no symptoms, containment becomes exponentially more difficult, similar to SARS-CoV-2. This would facilitate unchecked community spread. **Size: Large**.
-   **Effectiveness of Public Health Response:** The speed of contact tracing, isolation, and deployment of countermeasures (antivirals like oseltamivir, vaccines) upon detection of H2H transmission will determine if a nascent outbreak is contained. **Size: Moderate**.

### Differences vs. the base rate (what’s unusual now)
-   **Novel Mammalian Reservoir:** Unlike past avian flu threats, the current H5N1 clade (2.3.4.4b) has established a large, persistent reservoir in a mammal (dairy cattle) that has close contact with humans. This is a significant departure from a purely avian-to-human spillover model.
-   **High Intrinsic Severity:** H5N1 has a historically high case fatality rate (~50%). This is much higher than typical pandemic strains (e.g., 2009 H1N1 at <0.1%) and could lead to behavior that slows spread (e.g., rapid self-isolation) but also to more severe outcomes if it does spread.
-   **Post-COVID-19 Infrastructure:** The US has enhanced genomic sequencing, wastewater surveillance, and mRNA vaccine platforms that did not exist or were not at scale during previous pandemic threats. This allows for faster detection and response.
-   **Public Health Polarization:** Public trust in institutions like the CDC is lower than pre-2020, and compliance with public health measures (e.g., masking, vaccination) could be heavily politicized and fractured, potentially hampering a response.

### Bayesian update sketch (for the statistician)
-   **Prior:** Start with a low prior, anchored to the "Sporadic Zoonotic Spillover" reference class. A 1-3% chance seems appropriate, reflecting the historical rarity of such an event. (Equivalent n ≈ 50).
-   **Evidence mapping:**
    -   ↑ (Large): The establishment of a large, novel mammalian (cattle) reservoir fundamentally changes the exposure landscape and evolutionary opportunities for the virus.
    -   ↑ (Moderate): The 58 cases in 2024, while a small absolute number, represent a significant increase from the historical baseline, confirming spillover is occurring.
    -   ↑ (Moderate): The scientific clarification that a single, specific mutation (Q226L) is the key barrier makes the path to a pandemic seem less complex and more plausible.
    -   ↓ (Large): The continued, confirmed absence of efficient and sustained human-to-human transmission is the single most powerful piece of evidence keeping the probability low.
-   **Net effect:** The evidence strongly pushes the probability up from the historical base rate. The situation is far more concerning than at any point in the last 20 years for H5N1. However, the lack of H2H transmission remains a critical barrier. The posterior should be significantly higher than the prior, but still well below 50%.

### Indicators to watch (leading signals; next weeks/months)
-   **UP indicators:**
    -   Detection of the Q226L or similar receptor-binding mutations in any human or mammal isolate.
    -   A cluster of human cases with no clear link to animal exposure.
    -   Sustained positive H5N1 signals in urban wastewater surveillance systems.
    -   Reports of widespread H5N1 infection in other mammal species, especially swine.
    -   A significant, unexplained spike in influenza-like illness (ILI) in states with cattle outbreaks.
-   **DOWN indicators:**
    -   A decline in the rate of new human cases despite consistent surveillance.
    -   Evidence of successful containment and eradication of H5N1 in dairy cattle herds.
    -   Ongoing genomic surveillance of human and animal isolates showing no new significant mutations.
    -   Negative results from targeted seroprevalence studies among farm workers.

### Caveats & pitfalls
-   **Resolution Criteria:** The question resolves on *reported* cases (confirmed + probable). A lack of testing or restrictive testing criteria could lead to a significant undercount, causing the question to resolve "No" even if the true number is higher.
-   **Definition of "Probable":** The CDC's case definition for a "probable" case could be broadened or narrowed during an outbreak, which would directly impact the official tally for this question.
-   **Data Lags:** There are significant lags in testing, confirming, and reporting cases. A rapid outbreak in late 2025 might not have its cases fully reported by the Jan 1, 2026 deadline.
-   **Asymptomatic Spread:** If the virus spreads asymptomatically, surveillance focused on symptomatic individuals will miss the bulk of infections, making the 10,000 reported case threshold much harder to reach.
-   **Political Interference:** The reporting of

Market snapshot debug:
- Metaculus: no open binary results in response
- Manifold: no open binary results in response

### Sources
- Update: Outbreak of Severe Acute Respiratory Syndrome --- Worldwide, 2003 (www.cdc.gov) — https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5212a1.htm
- CDC SARS Response Timeline (www.cdc.gov) — https://www.cdc.gov/about/history/sars/timeline.htm
- Arrival of the 2024/25 Influenza Season in Hong Kong (www.chp.gov.hk) — https://www.chp.gov.hk/files/pdf/letters_to_doctors_20250109.pdf
- Communicable Diseases Watch, Volume 20, Issue 8 (www.chp.gov.hk) — https://www.chp.gov.hk/files/pdf/cdw_vol20_is8.pdf
- We Were There: Healthier Together: Highlighting 40 years of U.S. and China Public Health Collaborations (www.youtube.com) — https://www.youtube.com/watch?v=1y-gLd_yL-c
- CDC in China | Global Health (www.cdc.gov) — https://www.cdc.gov/globalhealth/countries/china/default.htm
- The Rise and Fall of the US-China Health Relationship (muse.jhu.edu) — https://muse.jhu.edu/pub/1/article/848831/summary
- Heads of China CDC and U.S. CDC hold virtual meeting on cooperation (www.chinacdc.cn) — https://www.chinacdc.cn/en/ne/202312/t20231226_271644.html

### Research (debug)

- source=GoogleGrounding | llm=google/gemini-2.5-pro | cached=0 | n_raw=8 | n_kept=8 | cost=$0.025229

- query: format; metac_closes_in_period; info; post_id; question_id; Will CDC; United States; Hong Kong; Low Historically; US Centers; Disease Control; 2026; 2003; 1997; 2016; 2024

### GTMC1 (debug)

- strategic_class=False | strategic_score=0.00 | source=llm

- gtmc1_active=False | qtype=binary | t_ms=0

- actors_parsed=0

- exceedance_ge_50=None | coalition_rate=None | median=None | dispersion=None

### Ensemble (model outputs)

- OpenRouter-Default: ok=True t_ms=13957 p=0.1500

- Claude-3.7-Sonnet (OR): ok=True t_ms=31192 p=0.1000

- Gemini: ok=True t_ms=98990 p=0.0400

- Grok: ok=False t_ms=391



### Per-model (raw + usage/cost)

#### OpenRouter-Default

- ok=True | t_ms=13957 | tokens: prompt=4036, completion=591, total=4627 | cost=$0.016000

```md

To forecast the probability of the CDC reporting 10,000 or more H5 avian influenza cases in the United States before January 1, 2026, we will follow a structured Bayesian reasoning approach.

### 1. Base Rate (Prior) Selection
The base rate for zoonotic spillover events leading to more than 10,000 cases in the US is extremely low, near 0%, based on historical data. However, considering the "Contained but Significant Novel Outbreaks" reference class, which includes events like Mpox, the base rate might be around 5-10%. Given the unique circumstances of H5N1, a prior probability of 3% seems reasonable, reflecting the historical rarity of such events but acknowledging the potential for significant outbreaks.

### 2. Comparison to Base Case
- **Similarities:** Historically, H5N1 has not led to widespread human outbreaks, aligning with the low base rate.
- **Differences:** The presence of a large mammalian reservoir (dairy cattle) and the identification of a single mutation (Q226L) that could facilitate human-to-human transmission are significant deviations from past scenarios. These factors increase the potential for a larger outbreak.

### 3. Evidence Evaluation (Likelihoods)
- **Large Mammalian Reservoir:** The establishment of H5N1 in cattle increases the likelihood of mutations favorable for human infection. This evidence increases the probability.
- **58 Human Cases in 2024:** This is a significant increase from historical baselines, indicating ongoing spillover. This evidence increases the probability.
- **Q226L Mutation:** The identification of a single mutation necessary for human adaptation lowers the barrier to a pandemic. This evidence increases the probability.
- **No Sustained Human-to-Human Transmission:** The absence of efficient human-to-human transmission is a critical factor keeping the probability low. This evidence decreases the probability.

### 4. Bayesian Updating (Posterior Probability)
Starting with a prior probability of 3%, the evidence of a large mammalian reservoir, increased human cases, and the potential for a critical mutation significantly raises the probability. However, the lack of sustained human-to-human transmission is a strong counterbalance. Conceptually, the posterior probability should be higher than the prior but remain below 50%.

### 5. Red Team Thinking
- **Overconfidence Risks:** The forecast might overestimate the impact of the Q226L mutation without evidence of its occurrence.
- **Alternative Scenarios:** A rapid development of effective vaccines or containment measures could prevent reaching 10,000 cases.
- **Rebuttals:** The absence of human-to-human transmission remains a strong argument against a large outbreak.

### 6. Final Forecast
Considering the base rate, evidence, and potential countermeasures, the final probability reflects a cautious increase from the prior, acknowledging the increased risk but also the significant barriers to a large outbreak.

Final: 15%

```

#### Claude-3.7-Sonnet (OR)

- ok=True | t_ms=31192 | tokens: prompt=4615, completion=1742, total=6357 | cost=$0.039975

```md

# Will CDC report 10,000+ H5 avian influenza cases in the US before January 1, 2026?

## 1. Base Rate (Prior) Selection

For this question, I need to identify an appropriate reference class of similar disease outbreaks to establish a base rate.

The most relevant reference classes are:
- Sporadic zoonotic spillover events (historical H5N1, MERS, etc.)
- Contained but significant novel outbreaks (Mpox 2022-23, SARS 2003)
- Pandemic influenza events (H1N1 2009)

Looking at historical data:
- H5N1 has caused only 58 US cases in 2024 (as of December 11, 2024)
- Prior to 2024, there was only 1 US H5N1 case
- Mpox reached over 30,000 US cases in 2022-23
- SARS-CoV-1 had only a handful of US cases
- H1N1 (2009) reached millions of US cases

Given that H5N1 remains primarily a zoonotic disease without confirmed human-to-human transmission, the most appropriate base rate comes from the "sporadic zoonotic spillover" reference class, with some weight given to the "contained but significant novel outbreaks" class due to the current cattle reservoir.

**Prior probability: 3%**

This reflects the historical rarity of zoonotic diseases reaching 10,000+ cases without efficient human-to-human transmission, while acknowledging the unusual cattle reservoir situation.

## 2. Comparison to Base Case

**Similarities to base case:**
- H5N1 remains primarily an animal virus with sporadic human spillover
- No confirmed human-to-human transmission has been documented
- Current case counts remain low (58 as of December 2024)
- Public health authorities maintain vigilance and monitoring

**Key differences:**
- Novel widespread mammalian reservoir (dairy cattle) provides more opportunities for human exposure and viral evolution
- Research has identified a single mutation (Q226L) that could enable human-to-human transmission
- Post-COVID surveillance infrastructure is more robust than during previous outbreaks
- We have over a year remaining until the resolution date (January 2026)
- Public health response may be hampered by polarization and distrust

These differences, particularly the cattle reservoir and identified mutation pathway, suggest the prior should be adjusted upward from the historical base rate for purely avian H5N1.

## 3. Evidence Evaluation

**Evidence 1: Establishment of H5N1 in US dairy cattle**
- P(E|H): Very high (~0.9) - A large mammalian reservoir would almost certainly be necessary for 10,000+ human cases
- P(E|~H): Moderate (~0.3) - The cattle outbreak could remain significant without leading to 10,000+ human cases
- Likelihood ratio: ~3.0
- Direction: Increases probability

**Evidence 2: 58 human cases in 2024 (as of December)**
- P(E|H): Very high (~0.95) - We would expect to see initial cases before a larger outbreak
- P(E|~H): Moderate (~0.4) - Sporadic cases are consistent with continued limited spillover
- Likelihood ratio: ~2.4
- Direction: Increases probability

**Evidence 3: Identification of Q226L mutation as key for human adaptation**
- P(E|H): High (~0.8) - Understanding the specific mutation pathway makes the scenario more plausible
- P(E|~H): Moderate (~0.5) - This knowledge doesn't guarantee the mutation will occur or spread
- Likelihood ratio: ~1.6
- Direction: Slightly increases probability

**Evidence 4: Continued absence of human-to-human transmission**
- P(E|H): Low (~0.2) - For 10,000+ cases to occur, H2H transmission would likely be detected by now
- P(E|~H): High (~0.8) - Continued absence of H2H transmission is consistent with the virus remaining primarily zoonotic
- Likelihood ratio: ~0.25
- Direction: Strongly decreases probability

## 4. Bayesian Updating

Starting with prior odds of 3:97 (3% probability):

Update for Evidence 1 (cattle reservoir):
- Prior odds: 3:97 = 0.031
- Likelihood ratio: 3.0
- Posterior odds: 0.031 × 3.0 = 0.093
- Posterior probability: 0.093/(1+0.093) = 8.5%

Update for Evidence 2 (58 human cases):
- Prior odds: 0.093
- Likelihood ratio: 2.4
- Posterior odds: 0.093 × 2.4 = 0.223
- Posterior probability: 0.223/(1+0.223) = 18.2%

Update for Evidence 3 (Q226L mutation pathway):
- Prior odds: 0.223
- Likelihood ratio: 1.6
- Posterior odds: 0.223 × 1.6 = 0.357
- Posterior probability: 0.357/(1+0.357) = 26.3%

Update for Evidence 4 (absence of H2H transmission):
- Prior odds: 0.357
- Likelihood ratio: 0.25
- Posterior odds: 0.357 × 0.25 = 0.089
- Posterior probability: 0.089/(1+0.089) = 8.2%

## 5. Red Team Thinking

**Potential blind spots:**
- I may be underestimating the probability of a sudden mutation enabling efficient H2H transmission
- The question resolves on reported cases, not actual infections - testing capacity and case definitions will significantly impact the outcome
- With over a year until resolution, there's substantial time for the situation to evolve
- I may be overweighting the historical rarity of H5N1 human cases and underweighting the novel cattle reservoir

**Alternative forecast (higher probability):**
A reasonable alternative forecast might be 15-20%, arguing that:
- The cattle reservoir is unprecedented and creates many more opportunities for viral evolution
- A single mutation could trigger efficient H2H transmission
- Once H2H transmission begins, exponential growth could quickly reach 10,000 cases
- The CDC might broaden case definitions during an outbreak, increasing reported numbers

**Rebuttal to higher forecast:**
- Even with H2H transmission, public health measures would likely be implemented quickly
- The virus would need to evolve both transmissibility and reduced severity (current ~50% CFR would trigger extreme measures)
- The January 2026 deadline gives limited time for a large outbreak to develop and be officially reported

**Adjustment:**
Given these considerations, I should adjust my forecast slightly upward from 8.2% to account for the unprecedented cattle reservoir and the time remaining until resolution.

## 6. Final Forecast

After considering the base rate, evidence, and potential blind spots, I arrive at a final probability of 10%.

This reflects:
- The historically low base rate of zoonotic diseases reaching 10,000+ cases
- The significant but not determinative impact of the cattle reservoir
- The critical absence of human-to-human transmission to date
- The time remaining until resolution (over a year)
- The uncertainty around viral evolution and potential for sudden changes

Final: 10%

```

#### Gemini

- ok=True | t_ms=98990 | tokens: prompt=4423, completion=1917, total=14706 | cost=$0.024699

```md

Here is a step-by-step probabilistic forecast based on the provided information.

### 1. Base Rate (Prior) Selection

The event in question is a large-scale outbreak (>10,000 reported cases) of a zoonotic virus in the US. The most appropriate reference class is not just any zoonotic spillover (which are common and usually tiny), but novel zoonotic threats that show some potential for wider spread.

*   **Reference Class: Significant Novel Zoonotic Outbreaks in the US (last 25 years).**
    *   SARS-CoV-1 (2003): No significant US outbreak (<10 cases).
    *   H1N1 Influenza (2009): Pandemic, millions of cases. (Crossed threshold)
    *   MERS-CoV (2012-): No significant US outbreak (2 cases).
    *   Zika (2015-16): Thousands of cases, but mostly travel-related. Local transmission was limited. Did not cross the 10,000 reported case threshold for local transmission.
    *   Mpox (2022-23): Significant outbreak, >30,000 cases. (Crossed threshold)
    *   COVID-19 (2020-): Pandemic, millions of cases. (Crossed threshold)

Out of six major threats, three led to outbreaks exceeding 10,000 cases in the US. However, H5N1 has been a known threat for decades without doing so. The key change in 2024 was its establishment in a large mammalian reservoir (dairy cattle), which significantly increases the risk compared to prior years.

Given this elevated risk, a simple base rate is insufficient. I will establish a subjective prior as of late 2024, for the period ending Jan 1, 2026. The situation is more dangerous than a typical year but lacks the key ingredient for a pandemic: sustained human-to-human (H2H) transmission. A 1-in-10 chance of this specific, known threat escalating to a major outbreak over the coming year seems like a reasonable starting point for a concerned but calibrated observer.

*   **Prior P(H): 10%** (Probability as of late 2024 that >10,000 cases would be reported by Jan 1, 2026).

### 2. Comparison to Base Case

The forecast is being made on November 6, 2025. The primary difference from the late 2024 base case is the passage of time. Nearly 11 months of the highest-risk period (the year 2025) have passed without the event occurring. This is strong evidence against the hypothesis. However, influenza viruses are seasonal, with transmission typically peaking in the winter. The highest-risk period is just beginning.

*   **Similarity:** The fundamental drivers identified in late 2024 (cattle reservoir, known mutation pathway) are still present.
*   **Difference:** We are now very close to the deadline, which dramatically shortens the window for an outbreak to start and grow to 10,000 reported cases. We are also entering the peak influenza season.

### 3. Evidence Evaluation (Likelihoods)

The most crucial piece of evidence is the passage of time and the seasonality of influenza.

*   **Evidence:** It is November 6, 2025, and the 10,000 case threshold has not been met.
*   **Analysis:** Let's model the 10% prior risk as being distributed across 2025. Influenza risk is not uniform; it's concentrated in the winter. Let's assume 75% of the risk for an outbreak starting is concentrated in the period from November to January, and 25% is in the February to October period.
    *   Prior risk for Feb-Oct 2025 = 10% * 0.25 = 2.5%
    *   Prior risk for Nov-Dec 2025 = 10% * 0.75 = 7.5%
*   We are forecasting on Nov 6, having "survived" the Feb-Oct period without the event occurring. We need to find the conditional probability of the event happening in the final ~2 months, given it hasn't happened yet.
    *   P(H in Nov-Dec | not H in Feb-Oct) = P(H in Nov-Dec) / P(not H in Feb-Oct)
    *   P(H in Nov-Dec) = 0.075
    *   P(not H in Feb-Oct) = 1 - 0.025 = 0.975
    *   Conditional Probability ≈ 0.075 / 0.975 ≈ 0.077 or **7.7%**.

This 7.7% represents the updated probability that an outbreak capable of reaching the threshold will *begin* in the remaining time.

### 4. Bayesian Updating (Posterior Probability)

Now, we must consider whether an outbreak starting in this short window can lead to 10,000 *reported* cases by the deadline. This involves two factors: containment failure and reporting speed.

1.  **Probability of Containment Failure:** Given the high alert status, an initial H2H cluster would trigger an intense public health response. However, experience with COVID-19 and Mpox shows that containing a respiratory or close-contact virus once community transmission begins is extremely difficult. Let's estimate the probability of the outbreak escaping initial containment at 80%.
2.  **Probability of Reaching 10k Reported Cases:** If an outbreak starts now, there are ~7.5 weeks until the deadline. The US took ~3 months to report 10,000 Mpox cases and ~3 weeks for the first 10,000 COVID-19 cases. H5N1 would be a top priority, likely accelerating reporting. It is plausible but not certain that the threshold would be officially met in time. Let's estimate the probability of the reporting system capturing >10,000 cases in time, given an uncontained outbreak, at 70%.

Combining these factors:
*   P(>10k reported cases | H2H outbreak begins) = P(Containment Fails) * P(Reporting threshold met | Containment Fails)
*   P(>10k reported cases | H2H outbreak begins) = 0.80 * 0.70 = 0.56 or **56%**.

Now, we perform the final update on our 7.7% probability:

*   **Posterior Probability** = P(H2H outbreak begins) × P(>10k reported cases | H2H outbreak begins)
*   **Posterior Probability** = 7.7% × 56% ≈ **4.3%**

### 5. Red Team Thinking

*   **Overconfidence Check:** My forecast hinges on several subjective estimates (10% prior, 75% seasonality, 56% chance of hitting the threshold post-H2H). These could be wrong.
*   **Alternative Scenario (Higher):** What if cryptic H2H transmission is already occurring? If an outbreak is already smoldering, the 7.7% probability is too low, as we are not waiting for it to start. In this case, the final probability would be closer to the 56% estimate. However, the lack of resolution implies this is not the widely accepted reality.
*   **Alternative Scenario (Lower):** The high case fatality rate of H5N1 (~50% historically) could dramatically alter public behavior, leading to rapid self-isolation and compliance that makes containment much more likely than my 80% failure estimate. If containment is, say, 50% likely to succeed, the final probability would drop to ~2.5%.
*   **Conclusion:** The 4.3% estimate seems to balance these competing factors. It acknowledges the grave risk posed by the situation while respecting the very short time remaining and the high hurdles (viral adaptation, escaping containment, rapid reporting) that must be cleared.

### 6. Final Forecast

The forecast is based on a 10% prior for a major outbreak in 2025, adjusted for the fact that we have entered the peak influenza season with only seven weeks remaining to the deadline. This updated probability of an outbreak starting is then discounted by the significant chance that even if an outbreak begins, it either will be contained or will not be fully reflected in official case counts by January 1, 2026.

Final: 4%

```

#### Grok

- ok=False | t_ms=391 | tokens: prompt=0, completion=0, total=0 | cost=$0.000000

- error=HTTP 429: Your team 0101076a-72f1-4f25-a038-b346d74bbc8d has either used all available credits or reached its monthly spending limit. To continue making API requests, please purchase more credits or raise your spending limit.

### Aggregation (BMC)

- final_probability=0.1213

- bmc_summary={"mean": 0.12129641990534576, "p10": 0.0007776697771296382, "p50": 0.05291209148765234, "p90": 0.3490882485278924}